Lisa Walter
Stock Analyst at RBC Capital
(3.67)
# 2,151
Out of 4,675 analysts
87
Total ratings
59.2%
Success rate
7.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lisa Walter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYPT EyePoint | Downgraded: Hold | $37 → $5 | $5.32 | -6.02% | 10 | Aug 17, 2026 | |
| KRYS Krystal Biotech | Initiated Coverage: Buy | $400 | $346.58 | +15.41% | 1 | Aug 14, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Buy | $35 | $15.83 | +121.10% | 25 | Aug 14, 2026 | |
| MGTX MeiraGTx Holdings | Reiterated: Buy | $26 → $27 | $14.34 | +88.28% | 9 | Aug 13, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $10 → $9 | $4.05 | +122.22% | 2 | Aug 6, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | $35 → $36 | $24.29 | +48.21% | 7 | Aug 6, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $148 → $135 | $96.31 | +40.17% | 3 | Aug 6, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $704 → $677 | $513.12 | +31.94% | 12 | Aug 5, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $141 → $155 | $110.00 | +40.91% | 7 | Aug 4, 2026 | |
| OCUL Ocular Therapeutix | Maintained: Buy | $30 | $11.08 | +170.76% | 11 | Aug 3, 2026 |
EyePoint
Aug 17, 2026
Downgraded: Hold
Price Target: $37 → $5
Current: $5.32
Upside: -6.02%
Krystal Biotech
Aug 14, 2026
Initiated Coverage: Buy
Price Target: $400
Current: $346.58
Upside: +15.41%
4D Molecular Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $35
Current: $15.83
Upside: +121.10%
MeiraGTx Holdings
Aug 13, 2026
Reiterated: Buy
Price Target: $26 → $27
Current: $14.34
Upside: +88.28%
Opus Genetics
Aug 6, 2026
Reiterated: Buy
Price Target: $10 → $9
Current: $4.05
Upside: +122.22%
Viridian Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $35 → $36
Current: $24.29
Upside: +48.21%
Mirum Pharmaceuticals
Aug 6, 2026
Maintained: Buy
Price Target: $148 → $135
Current: $96.31
Upside: +40.17%
United Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $704 → $677
Current: $513.12
Upside: +31.94%
Rhythm Pharmaceuticals
Aug 4, 2026
Reiterated: Buy
Price Target: $141 → $155
Current: $110.00
Upside: +40.91%
Ocular Therapeutix
Aug 3, 2026
Maintained: Buy
Price Target: $30
Current: $11.08
Upside: +170.76%